Skip to content
Companies

Azra AI

Cancer finding detection in pathology and radiology reports

Raised to date

$10.5M

of $10.5M offered across 1 Form D filing

Investors
73
Last filed
May 12, 2026

About

Azra AI is a Franklin, Tennessee healthcare software company whose AI platform reads pathology and radiology reports in real time to surface cancer diagnoses and suspicious incidental findings. It classifies findings by primary site and routes patients to navigators and care teams so treatment starts sooner, layering closed-loop workflows on top of the hospital's existing EHR, which remains the system of record. The company says its SaaS clinical intelligence product is used by more than 200 hospitals and cancer centers. Coverage has extended beyond oncology into radiology, cardiology, emergency medicine and clinical research programs.

Real-time AI detection of cancer and incidental findings wired directly into accountable patient-navigation workflows and bidirectional EHR integration, rather than a standalone analytics report.

Funding

  • EquityFiled May 12, 2026Form D
    $10.5M/ $10.5M

Product

Azra AI oncology platform

Clinical intelligence SaaS

An enterprise patient management and clinical intelligence platform that overlays a health system's EHR, using AI to identify cancer diagnoses and incidental findings in pathology and radiology reports and drive patients through defined care pathways.

  • Real-time AI analysis of pathology and radiology reports
  • Detection and classification of incidental findings by primary site
  • Automated routing to cancer navigators and care teams

Built for

Hospitals, health systems and cancer centers

People on file